The macrolides in modern algorithms of antibacterial therapy of community-acquired infections


Cite item

Full Text

Abstract

The present article discussed current insights of the etiology of community-acquired lower respiratory infections - pneumonia, exacerbation of chronic bronchitis or chronic obstructive pulmonary disease, which occupy a leading position in the structure of morbidity and mortality from infectious diseases. It is emphasized that the beta-lactams, "modern" macrolides (azithromycin, clarithromycin) and "respiratory" fluoroquinolones plays important role in the treatment of community-acquired lower respiratory infections in adult patients. According to the principles of rational antibiotic therapy, drug choice should be based on the pattern of disease adjusted for a number of factors (comorbidity, patient age, etc.) and pharmacoeconomic expediency.

About the authors

A A Zaytsev

A Zaytsev

References

  1. Чучалин А.Г., Синопальников А.И., Страчунский Л.С., и соавт. Внебольничная пневмония у взрослых. Практические рекомендации по диагностике, лечению и профилактике. М., 2006. 76 с.
  2. Woodhed M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005;26:1138-80.
  3. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. http://www.thoracic.org/sections/publications/statements/pages/mtpi/idsaats-cap.html
  4. Roche N, Huchon G. Epidemiology of chronic obstructive pulmonary disease. Rev Prat 2004;54(13):1408-13.
  5. World Health Report 2000. Health systems: improving performance. Annex table 3. 2000 World Health Organization. Geneva, Switzerland.
  6. Lopez AD, Murray C. The global burden of disease 1990-2020. Nat Med 1998;4:1241-3.
  7. Jokinen C, Heiskanen L, Juvonen H, et al. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in Eastern Europe. Clin Infect Dis 2001;32:1141-54.
  8. Marrie TJ, Peeling RW, Fine MJ, et al. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996;101:508-15.
  9. Lim WS, Macfarlane JT, Bosivell TC, et al. Study of community aacquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001;56:296-301.
  10. Kuo CC, Jackson LA, Campbell LA, et al. Chlamydia pneumoniae (TWAR). Clin Microb Rev 1995;8:451-61.
  11. Paganin F, Lilienthal F, Bourdin A, et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 2004;24:779-85.
  12. Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 2002;162:1849-58.
  13. Савинова Т.Л., Бейкин А.Б., Шилова В.П. с соавт. Практический опыт лабораторной диагностики внебольничных пневмоний // Клин. микробиол. антимикроб. химиотер. 2009. Т. 11. № 1. 79-85.
  14. Templeton K.E., Scheltinga S.A., Eeden W.C., et al. Inproved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis 2005;41:345-51.
  15. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008;63:42-8.
  16. Perez-Padilla R, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-9.
  17. Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease. Proc Am Thor Soc 2004;1:109-4.
  18. Donaldson GC, Seemungal T, Bhowmik A, et al. The relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52.
  19. Sethi S, Murphy TF. Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review. Clinical Microbiology Reviews 2001;14(2):336-63.
  20. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355.
  21. Canut A, Martın-Herrero JE, Labora A, et al. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model. J Antimicrob Chemother 2007;60:605-12.
  22. Martinez FJ, Anzueto A. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis. Am J Med 2005;118(7):39-44.
  23. Решедько Г.К., Козлов Р.С. Состояние резистентности к антиинфекционным химиопрепаратам в России в книге "Практическое руководство по антиинфекционной химиотерапии" / Под ред. Страчунский Л.С., Белоусов Ю.Б., Козлов С.И. М., 2007. С. 32-47.
  24. Ferech M, Coenen S, Malhotra-Kumar S, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 2006;58(2):401-7.
  25. Metz-Gercek S, Maieron A, Strau R, et al. Ten years of antibiotic consumption in ambulatory care: Trends in prescribing practice and antibiotic resistance in Austria. BMC Infectious Diseases 2009. http://www.biomedcentral.com/1471-2334/9/61
  26. Amsden GW. Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemoter 2005;55:10-21.
  27. Синопальников А.И., Зайцев А.А. Клиническая эффективность и безопасность ступенчатой монотерапии азитромицином у пациентов с внебольничной пневмонией в условиях стационара // Фарматека 2006. № 16 (131). C. 66-72.
  28. Roig J, Rello J. Legionnaires' disease: a rational approach to therapy. J Antimicrob Chemother 2003;51(5):1119-29.
  29. Синопальников А.И., Козлов Р.С., Романовских А.Г., Рачина С.А. Инфекционное обострение ХОБЛ: практические рекомендации по диагностике, лечению и профилактике // Российские Медицинские Вести 2006. № 1. C. 4-18.
  30. El Moussaoui R., Roede B.M., Speelman P., et al. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and CORD: a meta-analisis of double-blind studies. Thorax 2008;63(5):415-22.
  31. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2542&mid=1085056570&magid=188

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies